Fundraising Fox
/Companies
Sign in

VQ Biomedical

Apex, US · Founded 2023 · Delaware corporation · 3 known investors

Find your way into VQ Biomedical

129 people in our graph can introduce you to the VQ Biomedical team.

Sign up to see every warm intro you have to VQ Biomedical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the VQ Biomedical team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

VQ Biomedical is developing a minimally-invasive intravascular catheter that delivers supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure, providing gas exchange independent of the lungs. It is positioned as an alternative to mechanical ventilation and VV-ECMO in critical care settings.

BiotechHealthtechMedical Devices

Founders & leadership

VQ Biomedical was founded in 2023 by Galen Robertson, Tobias Straube, Stewart Farling, Marc Deshusses, and Bruce Klitzman.

GRGalen Robertson
Galen RobertsonCo-founder & CEO
TS
Tobias StraubeCo-founder & Chief Medical Officer
SFStewart Farling
Stewart FarlingCo-founder & Lead EngineerStewart Farling holds a B.S. and M.S. from North Carolina State University and a Ph.D. from Duke University. He has approximately a decade of experimental research experience spanning bench work and field deployment, along with consulting work in soil and groundwater remediation, and is now co-founder and lead engineer at VQ Biomedical after completing doctoral research on intravascular oxygenation methods at Duke.
MD
Marc DeshussesCo-founder & Principal Scientist
BK
Bruce KlitzmanCo-founder & Scientific Advisor

Board

DE
Daniel E. EstayBoard MemberExecutive Officer, Director at Sonovascular
JK
JOE KNIGHTBoard director

Investors · 3

Wolfpack Investor Networklisted by Wolfpack Investor NetworkRaleigh · $250K – $5M

How we know: Wolfpack Investor Network's portfolio page · funding news · press coverage · Not right? Tell us

DCP CapitalreportedCamana Bay, Grand Cayman

How we know: funding news · press coverage · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.6M disclosed across 1 round · 2024

▶$1.6MraisedMar 2025 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • MARC DESHUSSESDirector
  • TOBIAS STRAUBEExecutive Officer, Director
  • Daniel E. EstayDirector
  • GALEN ROBERTSONExecutive Officer, Director
  • JOE KNIGHTDirector
Offering amount
$1.6M
Amount sold
$1.6M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2023
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

CqmedicalCQ Medical develops patient positioning and immobilization products used in radiation therapy, including devices for brachytherapy, SBRT, SRS, and proton treatments. Its offerings serve oncology and radiotherapy clinicians treating cancer and conditions such as osteoarthritis.
BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Vektor MedicalVektor Medical develops patient-specific computational models of cardiac electrophysiology to support the diagnosis and treatment of heart arrhythmias. Its technology targets electrophysiologists and cardiologists working in cardiac rhythm management.
MobiamedicalMobia Medical (formerly MicroTransponder) develops Vivistim Paired VNS Therapy, an FDA-approved vagus nerve stimulation treatment for chronic ischemic stroke survivors with moderate to severe upper extremity impairment. It serves stroke patients and the clinicians who treat them in the medical device industry.

Companies working in the same space as VQ Biomedical.

Frequently asked questions

What does VQ Biomedical do?
VQ Biomedical is developing a minimally-invasive intravascular catheter that delivers supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure, providing gas exchange independent of the lungs. It is positioned as an alternative to mechanical ventilation and VV-ECMO in critical care settings.
Who founded VQ Biomedical?
VQ Biomedical was founded by Galen Robertson, Tobias Straube, Stewart Farling, Marc Deshusses, Bruce Klitzman in 2023.
Who are VQ Biomedical's investors?
VQ Biomedical's investors include Duke Capital Partners, Wolfpack Investor Network, DCP Capital.
How much funding has VQ Biomedical raised?
VQ Biomedical has disclosed $1.6M raised across 1 round.
Where is VQ Biomedical headquartered?
VQ Biomedical is headquartered in Apex, US.